Protocol Ledger

NCT07394153 · Phase II · RECRUITING

Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia

Interventional Phase II clinical trial protocol NCT07394153 sponsored by Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-04-15 Enrollment: 30 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07394153
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)30 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07394153
Protocol FieldVerified Registry Value
NCT IdentifierNCT07394153
Consolidated Lead SponsorGrupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment30 participants (ESTIMATED)
Registered Start Date2026-04-15
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI